Posted inNews and Updates
FDA Debates New Standards for Psychedelic Drug Therapy
The FDA is drafting new safety standards for psychedelic therapies after hearing expert testimony on clinical trial design, safety, and patient care.
Posted inNews and Updates
Nitinotes EASE™ Clinical Trial Begins at Gemelli Hospital
Nitinotes launches the EASE™ clinical trial at Italy’s Gemelli Hospital, advancing minimally invasive endoscopic suturing for obesity treatment.
Posted inNews and Updates
Pulse Biosciences Completes PRECISE-BTN Study Enrollment
Pulse Biosciences completes enrollment for the PRECISE-BTN study, evaluating the Vybrance system for minimally invasive treatment of benign thyroid nodules.
Posted inNews and Updates
Compass Pathways: Can Psychedelic Therapy Last Long-Term?
New data confirms long-term efficacy for COMP360 psilocybin, but Compass Pathways now faces the significant challenge of scaling psychedelic therapy safely.
Posted inNews and Updates
Adia Med Files Fifth 2026 Osteoarthritis Clinical Study
Adia Med has submitted its fifth 2026 clinical protocol to the IRB, testing a breakthrough one-time systemic treatment for osteoarthritis patients.
Posted inNews and Updates
New RNAi Therapy Shows Promise for Mixed Hyperlipidemia
Arrowhead Pharmaceuticals reports positive data for ARO-APOC3, a pioneering RNAi therapy targeting mixed hyperlipidemia to improve cardiovascular patient care.
Posted inNews and Updates
Boehringer Ingelheim Updates EASi-KIDNEY Trial Progress
Boehringer Ingelheim updates the EASi-KIDNEY trial on empagliflozin’s role in treating chronic kidney disease and preventing renal failure.
Posted inNews and Updates
New FDA Guidance Sets Path for Psychedelic Drug Approval
The FDA has released new guidelines for psychedelic drug trials. Learn how these regulatory standards will shape the future of mental health treatment.
Posted inNews and Updates
Ivonescimab Outperforms Pembrolizumab in NSCLC Trial
New trial data shows ivonescimab outperforms pembrolizumab in treating PD-L1-positive NSCLC, marking a major advancement in lung cancer immunotherapy.
Posted inNews and Updates
Clinical Trial Delays: Why IRB Review Errors Happen
Clinical trial start-ups are stalling due to IRB submission errors. Discover why misreading regulatory pathways is causing delays and how to fix them.